FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Hydrocortisone Tablets, USP
Status: Discontinuation
»Therapeutic Categories: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Pulmonary/Allergy

Expand all

Par Pharmaceutical (New 04/19/2019)

Company Contact Information:
800-828-9393

Presentation Posting Date Related Information
5 mg, bottle of 50 (NDC 0603-3899-19) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
10 mg, bottle of 100 (NDC 0603-3900-21) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
20 mg, bottle of 100 (NDC 0603-3901-21) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English